oxidopamine has been researched along with Teratocarcinoma in 2 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Teratocarcinoma: A malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. (Dorland, 27th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, KA | 2 |
Mendez, I | 2 |
Hong, M | 1 |
Sadi, D | 1 |
2 other studies available for oxidopamine and Teratocarcinoma
Article | Year |
---|---|
Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain.
Topics: Adrenergic Agents; Amphetamine; Animals; Axons; Behavior, Animal; Cell Differentiation; Cell Line, T | 2005 |
Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.
Topics: Amphetamine; Animals; Cell Count; Cell Line; Corpus Striatum; Disease Models, Animal; Dopamine; Fema | 2000 |